Skip to main content

Velcade News

FDA Approves Subcutaneous Administration of Velcade In All Approved Indications

CAMBRIDGE, Mass., January 23, 2012–Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Multiple Myeloma, Lymphoma

Velcade patient information at Drugs.com